API Flashcards

1
Q

Describe typical chemical API process

A

Receipt raw materials/solvents

Dispense quantities required

Initiate reaction sequences

Purify/isolate intermediates/ final substance

Final substance isolation

Dry/Filter

Micronize if required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are control parameters in typical API manufacture?

A

Weight, Temp, Time (rate of reaction), Pressure, filter size, drying time, drying temperature.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are typical API specifications?

A

Description
Assay
ID
Impurities (Rel sub, Res solvent, Elemental, E/L)

Physicochemical properties
Particle size
Polymorphic form
Chiral purity
Water content
Microbial limits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the QP legal issues with changing API supplier?

A

Need API QP declaration (Audit)
Need MA update
Need to have national competent authority approval for each batch if 3rd country

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the different API Purification methods?

A

Recrystalisation, Isolation, distillation, evaporation, Solvent extraction, Chromatography, Freeze drying.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What water grades are required for API? What if sterile API?

A

Potable, if sterile then need to be controlled for endotoxin and bacterial bioburden. Final processing step needs to be WFI. EMA guidance document.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe a typical virus/Cell based biologics/Biotech API process.

A

Receipt of raw materials- Natural in origin. Eggs or cells

Eggs/ Cells incubated to optimum growth state

Virus/ Cell DNA contains required material to illicit required immune response/ Create protein of interest

Virus/DNA inoculated into eggs/ cells

Cells/ Eggs act as bioreactor and multiply required virus or target protein under incubation

Cells/Eggs cooled to stop growth

Harvesting steps include clarification, Tangential flow filtration, centrifugation for purification

Dilute with buffer and sterile filtration for bulk material.

Subsequent steps to insert into final containers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are typical specifications for Biologics active substance?

Drug products?

A

Substance;

Appearance
ID
Impurities/Purity
Quantity
Potency

Product;

Appearance/Description
ID
Impurities/Purity
Quantity
Potency
Ph
Osmolality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are typical purification methods for biotech/biologic products

A

Clarification (course filtration)
Tangential flow filtration- separation method using Ultrafiltration.
Centrifugation- with sucrose gradient to allow extraction at specific RF value
Chromatography- separation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Where does GMP begin for different API manufacturing?

A

Chemical- Introduction of API starting material

Animal API- Introduction of API starting material

Plant API- Introduction of API starting material

Herbal extract- Further extraction

Powdered Herbs- Physical process/ packaging

Biotech fermentation- Maintenance of working cell bank

Classical fermentation- Introduction of cells into fermentation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the rules around API solvent recovery?

A

Allowed if;

-Approved procedure
-Recovery method approved
-Recovered solvent meets specification
-Allowable within MA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are API requirements for IMPs?

A

No guidance legally, section 19 of part 2 gives some guidance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do you control incoming materials for API manufacture?

A

Supplier assurance
Audits
Initial review of receipted goods- tampering/ labelling
Cleaning status and certification of transport
Loading vessels used and perform incoming ID test prior to process discharge.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When can you blend materials?

When can’t you blend materials?

A

Blending of materials of same specification is acceptable, combining fractions of a production process.

It is not acceptable to blend OOS API with in specification API to average out result.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is re-processing?

What is re-working?

A

Re-processing is introducing unreacted material back through the routine process stream (IPT shows incomplete reaction)- if done repeatedly, indicated non robust CPPs and consider revalidation.

Re-working is performed where material does not meet specification and is subject to deviation evaluation. Increased (Equivalency) testing and stability considerations are required as well as MA/CTA impact. May also require additional method validation due to ‘new’ outputs from new process steps.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the different impurity sources in Chemical API manufacture?

Biotech/Biologic manufacture?

A

Chemical;

ICH Q3 A,B, C, D,E

Chemical contamination;

Organics, Inorganics, Solvents
Related substances
Residual solvents
Elemental impurities- catalysts
E/L from filters

CROSS CONTAMINATION

Nitrosamine risks (Amine, recovered solvents, cross contamination, degredation)

Physical contamination;
Man
Material
Equipment
Environment - inadequate cleaning
Utility

Microbial;
Water sources, people

Biologic manufacture

Endogenous/exogenous contaminants

Biological;
Host cell material
Fermentation cell material
Virus
Prions
Protein sources
Blood impurities
Endotoxins

Chemical;
E/L- Filters

Physical;
As above

Microbial;

Water, Cellular material, people.

16
Q

What are the reporting requirements for impurities? Where is the guidance found?

A

ICHQ3B

MDD <2g/day, Report 0.05%, ID 0.1% (or 1mg/day), Qualify (Safety profile) 0.15%

MDD >2g/day, Report 0.03%, ID 0.05%, Qualify 0.05%.

17
Q

What are the different classes of solvent?

Where is guidance on this?

A

ICHQ3C- Residual solvents

Class 1- Avoid (Benzene, Carbon Tetrachloride)

Class 2- Limit 50-5000PPM (ACN, Methanol, Toluene)

Class 3- Low toxicity >5000PPM (Acetic acid, Acetone)

18
Q

What are the different classes of elemental impurity?

Where is guidance?

A

ICH Q3D- Elemental impurities
Commercial drug product

Risk assessment to any potential element that could be present

PDE limits defined

Class 1- Human Toxicants (Arsenic, Mercury, Lead)

Class 2a- High probability of presence in DP. Cobalt, Nickel, Vanadium.

Class 2b- Reduced probability- Gold, Silver.

Class 3- Low toxicity, Barium, Chromium 500ug day.

Other elements- Low inherent toxicity. Al, B Ca, Fe.

19
Q

What are common risk factors for Nitrosamine presence?

A

Amine group
Recovered solvents
Process degradants
Certain Packaging materials
Cross contamination

20
Q

What are the 3 steps of EMA guidance for Nitrosamines?

What actions are to be taken in the event of nitrosamine identification?

A
  1. Risk assess and evaluate possibility of nitrosamine presence in marketed products
  2. Test products at risk (report isolated nitrosamines to HA)
  3. Apply for MA changes to reduce risk

Actions in the event of identification- Utilise guidance in ICH M7- Mutagenic impurities. Consider lifetime exposure risk.

21
Q

What testing is required for Nitrosamines?

What guidance is there on specifications/tests?

A

Specialist technology- GC/HPLC- Mass spec detector. Validated methods

PhEur general chapter- 30PPB limit tests, Quantitative methods. Covers 7 known Nitrosamines and EDQM also provide reference standards.

22
Q

What are the legal documents associated with API manufacture?

A

2004/27/EC- EU
2012:1916- UK HMR
2015/c95/01- Distribution

23
Q

What is an API QP declaration?

What does an API site require?

What are the MHRA certificates issued to API manufacturers?

What are importation controls over APIs?

Any exceptions?

A

QP declaration for MA and variations to confirm audit performed and meets UK GMP requirements- Contracted out or done themselves. EMA guidance template.

API site requires certificate from NCA- inspection from NCA

MHRA registration and certificates issued are Importation, Manufacture, distribution- Guidance in flowchart for Ni and GB.

Importation controls under 2011/62/EC
- If not on approved country list for AS, NCA written confirmation needed for each batch.
- Must follow GMP for APIs (Part 2)
- Must follow distribution guidance (2015/C95/01)

Exception for NCA written confirmations would be if EU/UK has audited that site (positive outcome) and only to ensure availability of product.

24
Q

What is the impact on a variable potency or purity within API batches?

What is expected purity of APIs?

A

Lack of effect
Toxic doses - Side effects, ADRs
Impurity issues- ADRs, side reactions, Nitrosamines, isomerism.

Purity value >98%

25
Q

What factors can impact bioavailability?

A

Particle size of API
Homogeneity
Administration method
PKA/PH gradient / solubility
Absorption site condition
Polymorphic crystal structure of API

26
Q

What microbial control would you expect for non sterile APIs?

A

API process is hostile (solvents, temps)
Water as final purification step and final packaging are sources.
Biologics- many sources of exogenous contamination.

Non sterile- 100cfu/g TYMC, 1000Cfu/g TAMC

27
Q

What would you expect to be in a VMP for your API facility?

A

Overall policy for site
CPPs from development

Process;

CQAs for API
Impurity control
Purity control
Related CPPs for manufacturing

Equipment/Premises;
Annex 15
Calibration
Facility/ Utility
Prospective vs concurrent validation
Revalidation requirements

Cleaning;
Validated methods
Detailed protocol and report
Worst case, HBEL, PDE, Solubility
Visual examination
Recovery efficiency (swabs/rinse)
Clean/dirty hold times
Across manufacturing stream
Defined cleaning approach and documented procedure.

28
Q

What are the considerations for sterile APIs? Does API always have to be sterile for parenteral?

A

If final dosage form is sterile, API should also be sterile unless;

  1. Terminal sterilisation
  2. Sterile filtration step

Must still comply with endotoxin specifications and controlled bioburden.

If must be sterile API, then Annex 1 applies and annex 2 for biologics.

Media fill requirements for all steps.

29
Q

What are water quality requirements for APIs?

A

EMA guidance document- specific cases given.

Sterile- WFI for final purification
Non sterile API going into Parenteral- Purified water
All else- Potable water.